Nicotine therapeutic benefits: Difference between revisions
Added a "More Information" section |
|||
Line 22: | Line 22: | ||
=Movement Disorders (not diagnosis specific)= | =Movement Disorders (not diagnosis specific)= | ||
=Multiple Sclerosis - Humans / Experimental Autoimmune Encephalomyelitis (EAE) - Animals= | =Multiple Sclerosis - Humans / Experimental Autoimmune Encephalomyelitis (EAE) - Animals= | ||
=OCD (Obsessive Compulsive Disorder)= | =OCD (Obsessive Compulsive Disorder)= | ||
=Pain= | =Pain= | ||
Line 40: | Line 39: | ||
*Citation: Jarvik ME. Beneficial effects of nicotine. Br J Addict. 1991 May;86(5):571-5. doi: 10.1111/j.1360-0443.1991.tb01810.x. PMID: 1859921. | *Citation: Jarvik ME. Beneficial effects of nicotine. Br J Addict. 1991 May;86(5):571-5. doi: 10.1111/j.1360-0443.1991.tb01810.x. PMID: 1859921. | ||
*Acknowledgement: Supported by U. C. Tobacco-related Disease program, grant # RT87 and a grant from the John D. and Catherine T. MacArthur Foundation. | *Acknowledgement: Supported by U. C. Tobacco-related Disease program, grant # RT87 and a grant from the John D. and Catherine T. MacArthur Foundation. | ||
=More Information= | |||
==See also: [[Nicotine_Studies|List of researchers]] studying nicotine / tobacco harm reduction |